Driving autoreactive cells to distraction
Nature Immunology
September 28, 2009
How potentially autoreactive T cells are prevented from being 'switched on' is reported in a paper published online this week in Nature Immunology. Explaining how these potentially harmful cells are activated could lead to new therapies for the prevention of autoimmune diseases, such as diabetes.
Previous work showed that PD-1, a protein expressed on autoreactive T lymphocytes, is essential to prevent autoimmunity and maintain immune cell tolerance for self proteins in mice.
Using a mouse model of type 1 diabetes, Brian Fife and co-workers found that blockade of PD-1 caused a slowdown in the movement of autoreactive T cells. This decreased spontaneous movement allowed autoreactive T cells the opportunity to recognize pancreatic islet cell components. The subsequent release of proinflammatory mediators caused islet cell destruction and clinical diabetes.
Whether these findings are relevant to other T cell-driven autoimmune diseases remains to be seen.
doi: 10.1038/ni.1790
Research highlights
-
Aug 12
Ageing: Mutations in the ageing human heart identifiedNature Aging
-
Aug 12
Palaeontology: T. rex and relatives traded big eyes for bigger bitesCommunications Biology
-
Aug 10
Epidemiology: Estimating the risk of SARS-related coronaviruses from bats in Southeast AsiaNature Communications
-
Aug 5
Microbiology: Single switch makes Escherichia coli beneficial insect partnerNature Microbiology
-
Aug 5
Conservation: More than half of unassessable species may be at risk of extinctionCommunications Biology
-
Aug 4
Physiology: Restoring cellular functions in pigs after deathNature